2-(4-Amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3,4-dihydroxy-5-methylsulfanylmethyl-pyrrolidinium

ID: ALA1161749

PubChem CID: 23388831

Max Phase: Preclinical

Molecular Formula: C12H17N5O2S

Molecular Weight: 295.37

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CSCC1NC(c2c[nH]c3c(N)ncnc23)C(O)C1O

Standard InChI:  InChI=1S/C12H17N5O2S/c1-20-3-6-10(18)11(19)8(17-6)5-2-14-9-7(5)15-4-16-12(9)13/h2,4,6,8,10-11,14,17-19H,3H2,1H3,(H2,13,15,16)

Standard InChI Key:  PLIGEAXYYNDCDB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.7138   -1.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1852   -2.6281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2071   -3.7498    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5643   -3.1717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4539   -4.6676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9971   -5.0249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028    1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155    0.7475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5805   -2.5334    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9991    2.7132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3702   -5.4425    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4277   -6.4107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0596   -6.6118    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5158   -7.7217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  4  1  0
  1  5  1  0
  3  5  2  0
  3  6  1  0
  2  7  1  0
  1  8  2  0
  6  8  1  0
  7  9  1  0
  4 10  1  0
  9 10  1  0
  3 11  1  0
 11 12  2  0
  5 13  1  0
 12 14  1  0
 13 14  2  0
  7 15  1  0
 11 16  1  0
  9 17  1  0
 10 18  1  0
 18 19  1  0
 19 20  1  0
M  END

Associated Targets(Human)

MTAP Tchem S-methyl-5-thioadenosine phosphorylase (233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 295.37Molecular Weight (Monoisotopic): 295.1103AlogP: -0.36#Rotatable Bonds: 3
Polar Surface Area: 120.08Molecular Species: BASEHBA: 7HBD: 5
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.97CX Basic pKa: 8.70CX LogP: -0.66CX LogD: -1.98
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.52Np Likeness Score: 0.42

References

1. Evans GB, Furneaux RH, Lenz DH, Painter GF, Schramm VL, Singh V, Tyler PC..  (2005)  Second generation transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase.,  48  (14): [PMID:16000004] [10.1021/jm050269z]
2. Longshaw, Alistair I and 5 more authors.  2010-09-23  Design and synthesis of potent "sulfur-free" transition state analogue inhibitors of 5'-methylthioadenosine nucleosidase and 5'-methylthioadenosine phosphorylase.  [PMID:20718423]
3. Clinch, Keith and 8 more authors.  2012-09-01  Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics.  [PMID:22854195]
4. Evans, Gary B and 7 more authors.  2015-09-01  Tight binding enantiomers of pre-clinical drug candidates.  [PMID:26260335]
5. Harijan, Rajesh K and 7 more authors.  2019-04-11  Selective Inhibitors of Helicobacter pylori Methylthioadenosine Nucleosidase and Human Methylthioadenosine Phosphorylase.  [PMID:30860833]

Source